Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History

Valeant Pharmaceuticals International Inc T.VRX

Sector: Healthcare | Sub-Sector: Drug Manufacturers - Specialty & Generic
Alternate Symbol(s):  VRX

Valeant Pharmaceuticals International Inc is a specialty pharmaceutical and medical device company that develops, manufactures, and markets a range of generic and branded generic pharmaceuticals, over-the-counter products and medical devices.
Price: $129.19 | Change: +$0.84 | %Change: +0.65%
Volume: 564,642 | Day High/Low: N/A/N/A | 52 Week High/Low: 170.45/92.42

Snapshot

Last Traded: May 12, 2014 08:51 Transaction Volume: 564,642
Open: $129.19 Previous Close: $128.35
Bid: $132.50 Ask: $132.50
Bid Size: 300 Ask Size: 1,100
Market Cap: $43.1b Shares Out: 333.6m
PE Ratio: N/A Dividend Yield: N/A
Scale: 1d 5d 3m 6m 1y 2y 5y
Type: Line Area OHLC

Advanced Charts

Opinion

Magna International (T.MG) shareholders bask in glow of rising share price

Stockhouse members have their say as we feature today’s Top Poster, Bullboard, and Blog, and recognize noteworthy contributions from our community.

Stockhouse Editorial   April 22, 2014
0 stars

Drug ETFs Surge On M&A Activity (AGN, VRX, IHE, XPH, PPH, AZN)

Benzinga.com   April 22, 2014
0 stars

ETF Outlook For Tuesday, April 22, 2014 (PBS, IHE, IYT, EIRL, VRX, AGN, NFLX)

Benzinga.com   April 22, 2014
0 stars

Canadian Biotech comes back to life: A buyer's guide

Everything you could ever want to know about biotech, biomed and bio investments up north.

Tony Pullen   January 21, 2014
0 stars

Latest Bullboard Posts